Citation tallies are available on Google Scholar. Citation metrics are also available at Web of Science and Scholar GPS.
2024
Olsen RW, Wallner M, Rogawski MA: GABA-A receptors, seizures and epilepsy (Chapter 48). In, Jasper’s Basic Mechanisms of the Epilepsies, Fifth Edition (Noebels JL, Avoli M, Rogawski MA, Vezanni A, Delgado-Escueta AV, eds.), New York: Oxford University Press, 1025-1046; 2024 (full text here).
Rogawski MA. Treatment of Seizure Disorders (Chapter 21). In: Brody's Human Pharmacology, 7th Edition (Wecker L, Ingram SL, editors), Elsevier, 192–206 2025 (full text here).
Rogawski MA. Treatment of Seizure Disorders (Chapter 21). In: Brody's Human Pharmacology, 7th Edition (Wecker L, Ingram SL, editors), Elsevier, 192–206 2025 (full text here).
2023
Rogawski MA. Antiseizure Medications (Chapter 24). In: Katzung's Basic and Clinical Pharmacology, 16th Edition (Vanderah TW, editor), McGraw-Hill Education, 428–463; 2023 (full text here).
French JA, Porter RJ, Perucca E, Brodie MJ, Rogawski MA, Pimstone S, Aycardi E, Harden C, Qian J, Rosenblut CL, Kenney C, Beatch GN; X-TOLE Study Group. Efficacy and safety of XEN1101, a novel potassium channel opener, in adults with focal epilepsy: a Phase 2b randomized clinical trial. JAMA Neurol. 2023 Nov 1;80(11):1145-1154. https://jamanetwork.com/journals/jamaneurology/fullarticle/2809938
French JA, Porter RJ, Perucca E, Brodie MJ, Rogawski MA, Pimstone S, Aycardi E, Harden C, Qian J, Rosenblut CL, Kenney C, Beatch GN; X-TOLE Study Group. Efficacy and safety of XEN1101, a novel potassium channel opener, in adults with focal epilepsy: a Phase 2b randomized clinical trial. JAMA Neurol. 2023 Nov 1;80(11):1145-1154. https://jamanetwork.com/journals/jamaneurology/fullarticle/2809938
Bruun DA, Ma B, Chen YJ, Wu CY, Aleman M, Zolkowska D, Smiley-Jewell SM, Rogawski MA, Lein PJ. Tolerability and pharmacokinetics of intravenous allopregnanolone with and without midazolam pretreatment in two healthy dogs. Epilepsia Open. 2023 Jun;8(2):666-672. https://onlinelibrary.wiley.com/doi/10.1002/epi4.12723
Rogawski MA, Slatko G. A randomized, open-label, two-treatment crossover study to evaluate the effect of food on the pharmacokinetics of diazepam nasal spray in healthy adults. Epilepsia. 2023 Feb;64(2):364-373. https://onlinelibrary.wiley.com/doi/10.1111/epi.17459
2022
Vuu I, Patterson EE, Wu CY, Zolkowska D, Leppik IE, Rogawski MA, Worrell GA, Kremen V, Cloyd JC, Coles LD. Intravenous and intramuscular allopregnanolone for early treatment of status epilepticus: Pharmacokinetics, pharmacodynamics, and safety in dogs. J Pharmacol Exp Ther. 2022 Feb;380(2):104-113. https://doi.org/10.1124/jpet.121.000736
2021
Oskarsson B, Mauricio EA, Shah JS, Li Z, Rogawski MA. Cortical excitability threshold can be increased by the AMPA blocker Perampanel in amyotrophic lateral sclerosis. Muscle Nerve. 2021 May 19. https://10.1002/mus.27328 (full text also available here).
Zolkowska D, Dhir A, Rogawski MA. Perampanel, a potent AMPA receptor antagonist, protects against tetramethylenedisulfotetramine-induced seizures and lethality in mice: comparison with diazepam. Arch Toxicol (2021). https://doi.org/10.1007/s00204-021-03053-9 (full text also available here).
Zolkowska D, Wu CY, Rogawski MA. Intranasal allopregnanolone confers rapid seizure protection: Evidence for direct nose-to-brain delivery. Neurotherapeutics (2021). https://doi.org/10.1007/s13311-020-00985-5
Rogawski MA. Antiseizure Drugs (Chapter 24). In: Basic and Clinical Pharmacology, 15th Edition (Katzung BG, Vanderah TW, editors), McGraw-Hill Education, 2021: 422-455 (full text here).
Zolkowska D, Dhir A, Rogawski MA. Perampanel, a potent AMPA receptor antagonist, protects against tetramethylenedisulfotetramine-induced seizures and lethality in mice: comparison with diazepam. Arch Toxicol (2021). https://doi.org/10.1007/s00204-021-03053-9 (full text also available here).
Zolkowska D, Wu CY, Rogawski MA. Intranasal allopregnanolone confers rapid seizure protection: Evidence for direct nose-to-brain delivery. Neurotherapeutics (2021). https://doi.org/10.1007/s13311-020-00985-5
Rogawski MA. Antiseizure Drugs (Chapter 24). In: Basic and Clinical Pharmacology, 15th Edition (Katzung BG, Vanderah TW, editors), McGraw-Hill Education, 2021: 422-455 (full text here).
2020
Hernandez GD, Solinsky CM, Mack WJ, Kono N, Rodgers KE, Wu C-Y, Mollo AR, Lopez CM, Pawluczyk S, Bauer G, Matthews D, Shi Y, Law M, Rogawski MA, Schneider LS, Brinton RD. Safety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: A single and multiple ascending dose phase 1b/2a clinical trial. Alzheimer’s Dement. 2020;6:e12107. https://doi.org/10.1002/trc2.12107 https://alz-journals.onlinelibrary.wiley.com/doi/full/10.1002/trc2.12107 (pdf here).
Dhir A, Bruun DA, Guignet M, Tsai YH, González E, Calsbeek J, Vu J, Saito N, Tancredi DJ, Harvey DJ, Lein PJ, Rogawski MA. Allopregnanolone and perampanel as adjuncts to midazolam for treating diisopropylfluorophosphate-induced status epilepticus in rats. Ann N Y Acad Sci. 2020 Sep 11. https://doi.org/10.1111/nyas.14479.
Sills GJ, Rogawski MA. Mechanisms of action of currently used antiseizure drugs. Neuropharmacology 2020 May 15:107966.
https://doi.org/10.1016/j.neuropharm.2020.107966 (full text here).
Rogawski MA, Cavazos JE. Mechanisms of action of antiseizure medications (Chapter 41). In: Wyllie's treatment of epilepsy: principles and practice, Seventh edition (Wyllie E, editor-in-chief; Gidal BE, Goodkin HP, Jehi L, Loddenkemper T, associate editors), Wolters Kluwer, Philadelphia, 2020. (full text here).
Dhir A, Bruun DA, Guignet M, Tsai YH, González E, Calsbeek J, Vu J, Saito N, Tancredi DJ, Harvey DJ, Lein PJ, Rogawski MA. Allopregnanolone and perampanel as adjuncts to midazolam for treating diisopropylfluorophosphate-induced status epilepticus in rats. Ann N Y Acad Sci. 2020 Sep 11. https://doi.org/10.1111/nyas.14479.
Sills GJ, Rogawski MA. Mechanisms of action of currently used antiseizure drugs. Neuropharmacology 2020 May 15:107966.
https://doi.org/10.1016/j.neuropharm.2020.107966 (full text here).
Rogawski MA, Cavazos JE. Mechanisms of action of antiseizure medications (Chapter 41). In: Wyllie's treatment of epilepsy: principles and practice, Seventh edition (Wyllie E, editor-in-chief; Gidal BE, Goodkin HP, Jehi L, Loddenkemper T, associate editors), Wolters Kluwer, Philadelphia, 2020. (full text here).
2019
Rogawski MA, Heller AH. Diazepam buccal film for the treatment of acute seizures. Epilepsy Behav. 2019 Nov 5:106537. https://doi.org/10.1016/j.yebeh.2019.106537. Review. PubMed PMID: 31699662.
Rogawski MA. Reduced efficacy and risk of seizure aggravation when cannabidiol is used without clobazam. Epilepsy Behav. 2019 Sep 13:106506. http:/dx.doi.org/10.1016/j.yebeh.2019.106506. (full text here).
Rogawski MA. Reduced efficacy and risk of seizure aggravation when cannabidiol is used without clobazam. Epilepsy Behav. 2019 Sep 13:106506. http:/dx.doi.org/10.1016/j.yebeh.2019.106506. (full text here).
2018
Dhir A, Rogawski MA. Determination of minimal steady-state plasma level of diazepam causing seizure threshold elevation in rats. Epilepsia. 2018 May;59(5):935-944. https://doi.org/10.1111/epi.14069 (full text here).
Zolkowska D, Wu C-Y, Rogawski MA. Intramuscular allopregnanolone and ganaxolone in a mouse model of treatment resistant status epilepticus. Epilepsia. 2018 Feb 17. http://dx.doi.org/10.1111/epi.13999 (full text here).
Rogawski MA. Treatment of Seizure Disorders (Chapter 21). In: Brody's Human Pharmacology: Mechanism-Based Therapeutics, 6th Edition (Wecker L, editor), Mosby (Elsevier), 2019 (full text here).
Porter RJ, Rogawski MA. Antiseizure Drugs (Chapter 24). In: Basic and Clinical Pharmacology, 14th Edition (Katzung BG, editor), McGraw-Hill Education, 2018: 409–438 (full text here).
Zolkowska D, Wu C-Y, Rogawski MA. Intramuscular allopregnanolone and ganaxolone in a mouse model of treatment resistant status epilepticus. Epilepsia. 2018 Feb 17. http://dx.doi.org/10.1111/epi.13999 (full text here).
Rogawski MA. Treatment of Seizure Disorders (Chapter 21). In: Brody's Human Pharmacology: Mechanism-Based Therapeutics, 6th Edition (Wecker L, editor), Mosby (Elsevier), 2019 (full text here).
Porter RJ, Rogawski MA. Antiseizure Drugs (Chapter 24). In: Basic and Clinical Pharmacology, 14th Edition (Katzung BG, editor), McGraw-Hill Education, 2018: 409–438 (full text here).
2017
Klein P, Dingledine R, Aronica E, Bernard C, Blümcke I, Boison D, Brodie MJ, Brooks-Kayal AR, Engel J Jr, Forcelli PA, Hirsch LJ, Kaminski RM, Klitgaard H,
Kobow K, Lowenstein DH, Pearl PL, Pitkänen A, Puhakka N, Rogawski MA, Schmidt D, Sillanpää M, Sloviter RS, Steinhäuser C, Vezzani A, Walker MC, Löscher W.
Commonalities in epileptogenic processes from different acute brain insults: Do they translate? Epilepsia. 2017 Dec 15. http://dx.doi.org/10.1111/epi.13965. PubMed PMID: 29247482.
Chen C-Y, Di Lucenteb J, Linb Y-C, Liene C-C, Rogawski MA, Maezawa I, Jin L-W. Defective GABAergic neurotransmission in the nucleus tractus solitarius in Mecp2-null mice, a model of Rett syndrome. Neurobiology of Disease. 2017. https://ddoi.org/10.1016/j.nbd.2017.09.006oi.org/10.1016/j.nbd.2017.09.006. (proof here).
Wang JY, Trivedi AM, Carrillo NR, Yang J, Schneider A, Giulivi C, Adams P, Tassone F, Kim K, Rivera SM, Lubarr N, Wu CY, Irwin RW, Brinton RD, Olichney JM, Rogawski MA, Hagerman RJ. Open-Label allopregnanolone treatment of men with fragile X-associated tremor/ataxia Syndrome. Neurotherapeutics. 2017 Jul 13. http://dx.doi.org/10.1007/s13311-017-0555-6. PubMed PMID: 28707277 (full text here).
Dingledine R, Coulter DA, Fritsch B, Gorter JA, Lelutiu N, McNamara J, Nadler JV, Pitkänen A, Rogawski MA, Skene P, Sloviter RS, Wang Y, Wadman WJ, Wasterlain C, Roopra A. Transcriptional profile of hippocampal dentate granule cells in four rat epilepsy models. Scientific Data. 2017 May 9;4:170061. http://dx.doi.org/10.1038/sdata.2017.61. PubMed PMID: 28485718.
Nik AM, Pressly B, Singh V, Antrobus S, Hulsizer S, Rogawski MA, Wulff H, Pessah IN. Rapid throughput analysis of GABAA receptor subtype modulators and blockers using DiSBAC1(3) membrane potential red dye. Molecular Pharmacology. Jul;92(1):88-99. https://dx.doi.org/10.1124/mol.117.108563. Epub 2017 Apr 20. PubMed PMID: 28428226 (full text here).
Vaitkevicius H, Bobb W, Rosenthal ES, Rosand J, Husain AM, Reddy K, Rogawski MA, Cole AJ. First-in-man allopregnanolone use in super-refractory status epilepticus. Annals of Clinical and Translational Neurology. 2017 Apr 26;4(6):411-414. https://doi.org/10.1002/acn3.408. PubMed PMID: 28589168; PubMed Central PMCID: PMC5454395.
Lévesque M, Herrington R, Leclerc L, Rogawski MA, Avoli M. Allopregnanolone decreases interictal spiking and fast ripples in an animal model of mesial temporal lobe epilepsy. Neuropharmacology. 2017, http://dx.doi.org/10.1016/j.neuropharm.2017.04.020 (full text here).
Ciarlone SL, Wang X, Rogawski MA, Weeber EJ. Effects of the synthetic neurosteroid ganaxolone on seizure activity and behavioral deficits in an
Angelman syndrome mouse model. Neuropharmacology. 2017, http:/dx.doi.org/10.1016/j.neuropharm.2016.12.009. PubMed PMID: 27986596 (full text here).
Kobow K, Lowenstein DH, Pearl PL, Pitkänen A, Puhakka N, Rogawski MA, Schmidt D, Sillanpää M, Sloviter RS, Steinhäuser C, Vezzani A, Walker MC, Löscher W.
Commonalities in epileptogenic processes from different acute brain insults: Do they translate? Epilepsia. 2017 Dec 15. http://dx.doi.org/10.1111/epi.13965. PubMed PMID: 29247482.
Chen C-Y, Di Lucenteb J, Linb Y-C, Liene C-C, Rogawski MA, Maezawa I, Jin L-W. Defective GABAergic neurotransmission in the nucleus tractus solitarius in Mecp2-null mice, a model of Rett syndrome. Neurobiology of Disease. 2017. https://ddoi.org/10.1016/j.nbd.2017.09.006oi.org/10.1016/j.nbd.2017.09.006. (proof here).
Wang JY, Trivedi AM, Carrillo NR, Yang J, Schneider A, Giulivi C, Adams P, Tassone F, Kim K, Rivera SM, Lubarr N, Wu CY, Irwin RW, Brinton RD, Olichney JM, Rogawski MA, Hagerman RJ. Open-Label allopregnanolone treatment of men with fragile X-associated tremor/ataxia Syndrome. Neurotherapeutics. 2017 Jul 13. http://dx.doi.org/10.1007/s13311-017-0555-6. PubMed PMID: 28707277 (full text here).
Dingledine R, Coulter DA, Fritsch B, Gorter JA, Lelutiu N, McNamara J, Nadler JV, Pitkänen A, Rogawski MA, Skene P, Sloviter RS, Wang Y, Wadman WJ, Wasterlain C, Roopra A. Transcriptional profile of hippocampal dentate granule cells in four rat epilepsy models. Scientific Data. 2017 May 9;4:170061. http://dx.doi.org/10.1038/sdata.2017.61. PubMed PMID: 28485718.
Nik AM, Pressly B, Singh V, Antrobus S, Hulsizer S, Rogawski MA, Wulff H, Pessah IN. Rapid throughput analysis of GABAA receptor subtype modulators and blockers using DiSBAC1(3) membrane potential red dye. Molecular Pharmacology. Jul;92(1):88-99. https://dx.doi.org/10.1124/mol.117.108563. Epub 2017 Apr 20. PubMed PMID: 28428226 (full text here).
Vaitkevicius H, Bobb W, Rosenthal ES, Rosand J, Husain AM, Reddy K, Rogawski MA, Cole AJ. First-in-man allopregnanolone use in super-refractory status epilepticus. Annals of Clinical and Translational Neurology. 2017 Apr 26;4(6):411-414. https://doi.org/10.1002/acn3.408. PubMed PMID: 28589168; PubMed Central PMCID: PMC5454395.
Lévesque M, Herrington R, Leclerc L, Rogawski MA, Avoli M. Allopregnanolone decreases interictal spiking and fast ripples in an animal model of mesial temporal lobe epilepsy. Neuropharmacology. 2017, http://dx.doi.org/10.1016/j.neuropharm.2017.04.020 (full text here).
Ciarlone SL, Wang X, Rogawski MA, Weeber EJ. Effects of the synthetic neurosteroid ganaxolone on seizure activity and behavioral deficits in an
Angelman syndrome mouse model. Neuropharmacology. 2017, http:/dx.doi.org/10.1016/j.neuropharm.2016.12.009. PubMed PMID: 27986596 (full text here).
2016
Rogawski MA. A new SV2A ligand for epilepsy. Cell. 2016 Oct 20;167(3):587. http:/dx.doi.org/10.1016/j.cell.2016.09.057. PubMed PMID: 27768878 (full text here).
Pessah IN, Rogawski MA, Tancredi DJ, Wulff H, Zolkowska D, Bruun DA, Hammock BD, Lein PJ. Models to identify treatments for the acute and persistent effects of seizure-inducing chemical threat agents. Ann N Y Acad Sci. 2016 Jul 28. http://onlinelibrary.wiley.com/doi/10.1111/nyas.13137/full. PubMed PMID: 27467073.
Rogawski, MA. Perampanel (Chapter 59). In: Pellock’s Pediatric Epilepsy: Diagnosis and Therapy. Fourth Edition. Pellock JM, Nordli, Jr DR, Sankar R, Wheless JW, editors. Demos Medical Publishing, New York, 2017: 861-872 (full text here).
Rogawski MA, Löscher W, Rho JM. Mechanisms of action of antiseizure drugs and the ketogenic diet._ Cold Spring Harb Perspect Med. 2016. http://dx.doi.org/10.1101/cshperspect.a022780 (full text here).
Rogawski MA. A fatty acid in the MCT ketogenic diet for epilepsy treatment blocks AMPA receptors. Brain 2016 Feb;139(Pt 2):306-9. http://dx.doi.org/10.1093/brain/awv369
Kazdoba TM, Hagerman RJ, Zolkowska D, Rogawski MA, Crawley JN. Evaluation of the neuroactive steroid ganaxolone on social and repetitive behaviors in the BTBR mouse model of autism. Psychopharmacology (Berl). 2016 Jan;233(2):309-23. http://dx.doi.org/10.1007/s00213-015-4115-7 (full text here).
Pessah IN, Rogawski MA, Tancredi DJ, Wulff H, Zolkowska D, Bruun DA, Hammock BD, Lein PJ. Models to identify treatments for the acute and persistent effects of seizure-inducing chemical threat agents. Ann N Y Acad Sci. 2016 Jul 28. http://onlinelibrary.wiley.com/doi/10.1111/nyas.13137/full. PubMed PMID: 27467073.
Rogawski, MA. Perampanel (Chapter 59). In: Pellock’s Pediatric Epilepsy: Diagnosis and Therapy. Fourth Edition. Pellock JM, Nordli, Jr DR, Sankar R, Wheless JW, editors. Demos Medical Publishing, New York, 2017: 861-872 (full text here).
Rogawski MA, Löscher W, Rho JM. Mechanisms of action of antiseizure drugs and the ketogenic diet._ Cold Spring Harb Perspect Med. 2016. http://dx.doi.org/10.1101/cshperspect.a022780 (full text here).
Rogawski MA. A fatty acid in the MCT ketogenic diet for epilepsy treatment blocks AMPA receptors. Brain 2016 Feb;139(Pt 2):306-9. http://dx.doi.org/10.1093/brain/awv369
Kazdoba TM, Hagerman RJ, Zolkowska D, Rogawski MA, Crawley JN. Evaluation of the neuroactive steroid ganaxolone on social and repetitive behaviors in the BTBR mouse model of autism. Psychopharmacology (Berl). 2016 Jan;233(2):309-23. http://dx.doi.org/10.1007/s00213-015-4115-7 (full text here).
2015
Mintzer S, French JA, Perucca E, Cramer JA, Messenheimer JA, Blum DE, Rogawski MA, Baulac M. Is a separate monotherapy indication warranted for antiepileptic drugs? Lancet Neurol. 2015 Dec;14(12):1229-40. http://dx.doi.org/10.1016/S1474-4422(15)00229-X. Review. PubMed PMID: 26581972.
Desai R, Savechenkov PY, Zolkowska D, Ge RL, Rogawski MA, Bruzik KS, Forman SA, Raines DE, Miller KW. Contrasting actions of a convulsant barbiturate and its anti-convulsant enantiomer on the α1β3γ2L GABA-A receptor account for their in vivo effects. J Physiol. 2015 Nov 15; 593(22):4943-61. http://dx.doi.org/10.1113/JP270971. PubMed PMID: 26378885.
Irwin RW, Solinsky CM, Loya CM, Salituro FG, Rodgers KE, Bauer G, Rogawski MA, Brinton RD. Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer's disease. PLoS One. 2015 Jun 3;10(6):e0128313. http://dx.doi.org/10.1371/journal.pone.0128313. eCollection 2015.
Bruun DA, Cao Z, Inceoglu B, Vito ST, Austin AT, Hulsizer S, Hammock BD, Tancredi DJ, Rogawski MA, Pessah IN, Lein PJ. Combined treatment with diazepam and allopregnanolone reverses tetramethylenedisulfotetramine (TETS)-induced calcium dysregulation in cultured neurons and protects TETS-intoxicated mice against lethal seizures. Neuropharmacology. 2015 Aug;95:332-42. http://dx.doi.org/10.1016/j.neuropharm.2015.03.035. PubMed PMID: 25882826.
Rogawski MA, Tofighy A, White HS, Matagne A, Wolff C. Current understanding of the mechanism of action of the antiepileptic drug lacosamide. Epilepsy Res. 2015 Feb;110C:189-205. http://dx.doi.org/10.1016/j.eplepsyres.2014.11.021. Epub 2014 Dec 3. Review. PubMed PMID: 25616473.
Rogawski MA, Cavazos JE. Mechanisms of action of antiepileptic drugs (Chapter 43). In: Wyllie's treatment of epilepsy: principles and practice, Sixth edition (Wyllie E, editor-in-chief; Gidal BE, Goodkin HP, Loddenkemper T, Sirven J, associate editors), Wolters Kluwer, Philadelphia, 2015: 522-529.
Desai R, Savechenkov PY, Zolkowska D, Ge RL, Rogawski MA, Bruzik KS, Forman SA, Raines DE, Miller KW. Contrasting actions of a convulsant barbiturate and its anti-convulsant enantiomer on the α1β3γ2L GABA-A receptor account for their in vivo effects. J Physiol. 2015 Nov 15; 593(22):4943-61. http://dx.doi.org/10.1113/JP270971. PubMed PMID: 26378885.
Irwin RW, Solinsky CM, Loya CM, Salituro FG, Rodgers KE, Bauer G, Rogawski MA, Brinton RD. Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer's disease. PLoS One. 2015 Jun 3;10(6):e0128313. http://dx.doi.org/10.1371/journal.pone.0128313. eCollection 2015.
Bruun DA, Cao Z, Inceoglu B, Vito ST, Austin AT, Hulsizer S, Hammock BD, Tancredi DJ, Rogawski MA, Pessah IN, Lein PJ. Combined treatment with diazepam and allopregnanolone reverses tetramethylenedisulfotetramine (TETS)-induced calcium dysregulation in cultured neurons and protects TETS-intoxicated mice against lethal seizures. Neuropharmacology. 2015 Aug;95:332-42. http://dx.doi.org/10.1016/j.neuropharm.2015.03.035. PubMed PMID: 25882826.
Rogawski MA, Tofighy A, White HS, Matagne A, Wolff C. Current understanding of the mechanism of action of the antiepileptic drug lacosamide. Epilepsy Res. 2015 Feb;110C:189-205. http://dx.doi.org/10.1016/j.eplepsyres.2014.11.021. Epub 2014 Dec 3. Review. PubMed PMID: 25616473.
Rogawski MA, Cavazos JE. Mechanisms of action of antiepileptic drugs (Chapter 43). In: Wyllie's treatment of epilepsy: principles and practice, Sixth edition (Wyllie E, editor-in-chief; Gidal BE, Goodkin HP, Loddenkemper T, Sirven J, associate editors), Wolters Kluwer, Philadelphia, 2015: 522-529.
2014
Vito ST, Austin AT, Banks CN, Inceoglu B, Bruun DA, Zolkowska D, Tancredi DJ, Rogawski MA, Hammock BD, Lein PJ. Post-exposure administration of diazepam combined with soluble epoxide hydrolase inhibition stops seizures and modulates neuroinflammation in a murine model of acute TETS intoxication. Toxicol Appl Pharmacol. 2014 Dec 1;281(2):185-94. http://dx.doi.org/10.1016/j.taap.2014.10.001. Epub 2014 Oct 14. PubMed PMID: 25448683; PubMed Central PMCID: PMC4258121.
Broomall E, Natale JE, Grimason M, Goldstein J, Smith CM, Chang C, Kanes S, Rogawski MA, Wainwright MS. Pediatric super-refractory status epilepticus treated with allopregnanolone. Ann Neurol. 2014 Dec;76(6):911-5. http://10.1002/ana.24295. Epub 2014 Nov 11. PubMed PMID: 25363147
Coleman N, Nguyen HM, Cao Z, Brown BM, Jenkins DP, Zolkowska D, Chen YJ, Tanaka BS, Goldin AL, Rogawski MA, Pessah IN, Wulff H. The riluzole derivative 2-amino-6-trifluoromethylthio-benzothiazole (SKA-19), a mixed K(Ca)2 activator and Na(V) blocker, is a potent novel anticonvulsant. Neurotherapeutics. 2014 Sep 26. [Epub ahead of print] PubMed PMID: 25256961.
Chen CY, Matt L, Hell JW, Rogawski MA. Perampanel inhibition of AMPA receptor currents in cultured hippocampal neurons. PLoS One. 2014 Sep 17;9(9):e108021. http://dx.doi.org/10.1371/journal.pone.0108021. PubMed PMID: 25229608.
Fritsch B, Reis J, Gasior M, Kaminski RM, Rogawski MA. Role of GluK1 kainate receptors in seizures, epileptic discharges, and epileptogenesis. J Neurosci. 2014 Apr 23;34(17):5765-75. http://dx.doi.org/10.1523/JNEUROSCI.5307-13.2014. PubMed PMID: 24760837; PubMed Central PMCID: PMC3996208. [This paper was the "Featured Article" in the Neurobiology of Disease section of the March 23, 2014 issue with editor comment.]
Zolkowska D, Dhir A, Krishnan K, Covey DF, Rogawski MA. Anticonvulsant potencies of the enantiomers of the neurosteroids androsterone and
etiocholanolone exceed those of the natural forms. Psychopharmacology (Berl). 2014 Sep;231(17):3325-32. http://dx.doi.org/10.1007/s00213-014-3546-x. Epub 2014 Apr 5. PubMed PMID: 24705905; PubMed Central PMCID: PMC4134984.
Kaminski RM, Rogawski MA, Klitgaard H. The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments. Neurotherapeutics. 2014 Apr;11(2):385-400. http://dx.doi.org/10.1007/s13311-014-0266-1. PubMed PMID: 24671870; PubMed Central PMCID: PMC3996125 (full text here).
Broomall E, Natale JE, Grimason M, Goldstein J, Smith CM, Chang C, Kanes S, Rogawski MA, Wainwright MS. Pediatric super-refractory status epilepticus treated with allopregnanolone. Ann Neurol. 2014 Dec;76(6):911-5. http://10.1002/ana.24295. Epub 2014 Nov 11. PubMed PMID: 25363147
Coleman N, Nguyen HM, Cao Z, Brown BM, Jenkins DP, Zolkowska D, Chen YJ, Tanaka BS, Goldin AL, Rogawski MA, Pessah IN, Wulff H. The riluzole derivative 2-amino-6-trifluoromethylthio-benzothiazole (SKA-19), a mixed K(Ca)2 activator and Na(V) blocker, is a potent novel anticonvulsant. Neurotherapeutics. 2014 Sep 26. [Epub ahead of print] PubMed PMID: 25256961.
Chen CY, Matt L, Hell JW, Rogawski MA. Perampanel inhibition of AMPA receptor currents in cultured hippocampal neurons. PLoS One. 2014 Sep 17;9(9):e108021. http://dx.doi.org/10.1371/journal.pone.0108021. PubMed PMID: 25229608.
Fritsch B, Reis J, Gasior M, Kaminski RM, Rogawski MA. Role of GluK1 kainate receptors in seizures, epileptic discharges, and epileptogenesis. J Neurosci. 2014 Apr 23;34(17):5765-75. http://dx.doi.org/10.1523/JNEUROSCI.5307-13.2014. PubMed PMID: 24760837; PubMed Central PMCID: PMC3996208. [This paper was the "Featured Article" in the Neurobiology of Disease section of the March 23, 2014 issue with editor comment.]
Zolkowska D, Dhir A, Krishnan K, Covey DF, Rogawski MA. Anticonvulsant potencies of the enantiomers of the neurosteroids androsterone and
etiocholanolone exceed those of the natural forms. Psychopharmacology (Berl). 2014 Sep;231(17):3325-32. http://dx.doi.org/10.1007/s00213-014-3546-x. Epub 2014 Apr 5. PubMed PMID: 24705905; PubMed Central PMCID: PMC4134984.
Kaminski RM, Rogawski MA, Klitgaard H. The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments. Neurotherapeutics. 2014 Apr;11(2):385-400. http://dx.doi.org/10.1007/s13311-014-0266-1. PubMed PMID: 24671870; PubMed Central PMCID: PMC3996125 (full text here).
2013
Inceoglu B, Zolkowska D, Yoo HJ, Wagner KM, Yang J, Hackett E, Hwang SH, Lee KS, Rogawski MA, Morisseau C, Hammock BD. Epoxy fatty acids and inhibition of the soluble epoxide hydrolase selectively modulate GABA mediated neurotransmission to delay onset of seizures. PLoS One. 2013 Dec 11;8(12):e80922. http://dx.doi.org/10.1371/journal.pone.0080922. PubMed PMID: 24349022; PubMed Central PMCID: PMC3862847.
Rogawski MA, Loya CM, Reddy K, Zolkowska D, Lossin C. Neuroactive steroids for the treatment of status epilepticus. Epilepsia. 2013 Sep;54 Suppl 6:93-8. http://dx.doi.org/10.1111/epi.12289. Review. PubMed PMID: 24001085; PubMed Central PMCID: PMC3772544.
Wilcox KS, Dixon-Salazar T, Sills GJ, Ben-Menachem E, White HS, Porter RJ, Dichter MA, Moshé SL, Noebels JL, Privitera MD, Rogawski MA. Issues related to development of new antiseizure treatments. Epilepsia. 2013 Aug;54 Suppl 4:24-34. http://dx.doi.org/10.1111/epi.12296. Review. PubMed PMID: 23909851.
Galanopoulou AS, Kokaia M, Loeb JA, Nehlig A, Pitkänen A, Rogawski MA, Staley KJ, Whittemore VH, Edward Dudek F. Epilepsy therapy development: technical and methodologic issues in studies with animal models. Epilepsia. 2013 Aug;54 Suppl 4:13-23. http://dx.doi.org/10.1111/epi.12295. Review. PubMed PMID: 23909850; PubMed CentralPMCID: PMC3747731.
Bröer S, Zolkowska D, Gernert M, Rogawski MA. Proconvulsant actions of intrahippocampal botulinum neurotoxin B in the rat. Neuroscience. 2013 Nov 12;252:253-61. http://dx.doi.org/10.1016/j.neuroscience.2013.07.050. Epub 2013 Jul 29. PubMed PMID: 23906638.
Dhir A, Zolkowska D, Rogawski MA. Seizure protection by intrapulmonary delivery of midazolam in mice. Neuropharmacology. 2013 Oct;73:425-31. http://dx.doi.org/10.1016/j.neuropharm.2013.06.002. Epub 2013 Jun 15. PubMed PMID: 23774136.
Gasior M, Tang R, Rogawski MA. Long-lasting attenuation of amygdala-kindled seizures after convection-enhanced delivery of botulinum neurotoxins A and B into the amygdala in rats. J Pharmacol Exp Ther. 2013 Sep;346(3):528-34. http://dx.doi.org/10.1124/jpet.113.205070. Epub 2013 Jun 14. PubMed PMID: 23772062.
Rogawski MA. The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs. Epilepsia. 2013 May;54 Suppl 2:33-40. http://dx.doi.org/10.1111/epi.12182. Review. PubMed PMID: 23646969.
Rogawski MA, Hanada T. Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist. Acta Neurol Scand Suppl. 2013;(197):19-24. http://dx.doi.org/10.1111/ane.12100. Review. PubMed PMID: 23480152.
Rogawski MA. AMPA receptors as a molecular target in epilepsy therapy. Acta Neurol Scand Suppl. 2013;(197):9-18. http://dx.doi.org/10.1111/ane.12099. Review. PubMed PMID: 23480151.
Devinsky O, Vezzani A, Najjar S, De Lanerolle NC, Rogawski MA. Glia andepilepsy: excitability and inflammation. Trends Neurosci. 2013 Mar;36(3):174-84. http://dx.doi.org/10.1016/j.tins.2012.11.008. Epub 2013 Jan 5. Review. PubMed PMID: 23298414.
Rogawski MA, Loya CM, Reddy K, Zolkowska D, Lossin C. Neuroactive steroids for the treatment of status epilepticus. Epilepsia. 2013 Sep;54 Suppl 6:93-8. http://dx.doi.org/10.1111/epi.12289. Review. PubMed PMID: 24001085; PubMed Central PMCID: PMC3772544.
Wilcox KS, Dixon-Salazar T, Sills GJ, Ben-Menachem E, White HS, Porter RJ, Dichter MA, Moshé SL, Noebels JL, Privitera MD, Rogawski MA. Issues related to development of new antiseizure treatments. Epilepsia. 2013 Aug;54 Suppl 4:24-34. http://dx.doi.org/10.1111/epi.12296. Review. PubMed PMID: 23909851.
Galanopoulou AS, Kokaia M, Loeb JA, Nehlig A, Pitkänen A, Rogawski MA, Staley KJ, Whittemore VH, Edward Dudek F. Epilepsy therapy development: technical and methodologic issues in studies with animal models. Epilepsia. 2013 Aug;54 Suppl 4:13-23. http://dx.doi.org/10.1111/epi.12295. Review. PubMed PMID: 23909850; PubMed CentralPMCID: PMC3747731.
Bröer S, Zolkowska D, Gernert M, Rogawski MA. Proconvulsant actions of intrahippocampal botulinum neurotoxin B in the rat. Neuroscience. 2013 Nov 12;252:253-61. http://dx.doi.org/10.1016/j.neuroscience.2013.07.050. Epub 2013 Jul 29. PubMed PMID: 23906638.
Dhir A, Zolkowska D, Rogawski MA. Seizure protection by intrapulmonary delivery of midazolam in mice. Neuropharmacology. 2013 Oct;73:425-31. http://dx.doi.org/10.1016/j.neuropharm.2013.06.002. Epub 2013 Jun 15. PubMed PMID: 23774136.
Gasior M, Tang R, Rogawski MA. Long-lasting attenuation of amygdala-kindled seizures after convection-enhanced delivery of botulinum neurotoxins A and B into the amygdala in rats. J Pharmacol Exp Ther. 2013 Sep;346(3):528-34. http://dx.doi.org/10.1124/jpet.113.205070. Epub 2013 Jun 14. PubMed PMID: 23772062.
Rogawski MA. The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs. Epilepsia. 2013 May;54 Suppl 2:33-40. http://dx.doi.org/10.1111/epi.12182. Review. PubMed PMID: 23646969.
Rogawski MA, Hanada T. Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist. Acta Neurol Scand Suppl. 2013;(197):19-24. http://dx.doi.org/10.1111/ane.12100. Review. PubMed PMID: 23480152.
Rogawski MA. AMPA receptors as a molecular target in epilepsy therapy. Acta Neurol Scand Suppl. 2013;(197):9-18. http://dx.doi.org/10.1111/ane.12099. Review. PubMed PMID: 23480151.
Devinsky O, Vezzani A, Najjar S, De Lanerolle NC, Rogawski MA. Glia andepilepsy: excitability and inflammation. Trends Neurosci. 2013 Mar;36(3):174-84. http://dx.doi.org/10.1016/j.tins.2012.11.008. Epub 2013 Jan 5. Review. PubMed PMID: 23298414.
2012
Löscher W, Rogawski MA. How theories evolved concerning the mechanism of action of barbiturates. Epilepsia. 2012 Dec;53 Suppl 8:12-25. http://dx.doi.org/10.1111/epi.12025. PubMed PMID: 23205959.
Porter RJ, Dhir A, Macdonald RL, Rogawski MA. Mechanisms of action of antiseizure drugs. Handb Clin Neurol. 2012;108:663-81. http://dx.doi.org/10.1016/B978-0-444-52899-5.00021-6. Review. PubMed PMID: 22939059.
Lossin C, Nam TS, Shahangian S, Rogawski MA, Choi SY, Kim MK, Sunwoo IN. Altered fast and slow inactivation of the N440K Nav1.4 mutant in a periodic paralysis syndrome. Neurology. 2012 Sep 4;79(10):1033-40. http://dx.doi.org/10.1212/WNL.0b013e3182684683. Epub 2012 Aug 22. PubMed PMID: 22914841.
Cao Z, Hammock BD, McCoy M, Rogawski MA, Lein PJ, Pessah IN. Tetramethylenedisulfotetramine alters Ca²+ dynamics in cultured hippocampal neurons: mitigation by NMDA receptor blockade and GABA(A) receptor-positive modulation. Toxicol Sci. 2012 Dec;130(2):362-72. http://dx.doi.org/10.1093/toxsci/kfs244. Epub 2012 Aug 13. PubMed PMID: 22889812; PubMed Central PMCID: PMC3529644.
French JA, Krauss GL, Biton V, Squillacote D, Yang H, Laurenza A, Kumar D, Rogawski MA. Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304. Neurology. 2012 Aug 7;79(6):589-96. http://dx.doi.org/10.1212/WNL.0b013e3182635735. Epub 2012 Jul 25. PubMed PMID: 22843280; PubMed Central PMCID: PMC3413761.
Rogawski MA. Migraine and Epilepsy—Shared Mechanisms within the Family of Episodic Disorders. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, editors. Jasper's Basic Mechanisms of the Epilepsies [Internet]. 4th edition. Bethesda (MD): National Center for Biotechnology Information (US); 2012. Available from http://www.ncbi.nlm.nih.gov/books/NBK98193/ PubMed PMID: 22787613.
Reddy DS, Rogawski MA. Neurosteroids — Endogenous Regulators of Seizure Susceptibility and Role in the Treatment of Epilepsy. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, editors. Jasper's Basic Mechanisms of the Epilepsies [Internet]. 4th edition. Bethesda (MD): National Center for Biotechnology Information (US); 2012. Available from http://www.ncbi.nlm.nih.gov/books/NBK98218/ PubMed PMID: 22787590.
Lossin C, Shi X, Rogawski MA, Hirose S. Compromised function in the Na(v)1.2 Dravet syndrome mutation R1312T. Neurobiol Dis. 2012 Sep;47(3):378-84. http://dx.doi.org/10.1016/j.nbd.2012.05.017. Epub 2012 Jun 4. PubMed PMID: 22677033.
Cao Z, Hulsizer S, Tassone F, Tang HT, Hagerman RJ, Rogawski MA, Hagerman PJ, Pessah IN. Clustered burst firing in FMR1 premutation hippocampal neurons: amelioration with allopregnanolone. Hum Mol Genet. 2012 Jul 1;21(13):2923-35. http://dx.doi.org/10.1093/hmg/dds118. Epub 2012 Mar 30. PubMed PMID: 22466801; PubMed Central PMCID: PMC3373240.
Dhir A, Lossin C, Rogawski MA. Propofol hemisuccinate suppresses cortical spreading depression. Neurosci Lett. 2012 Apr 11;514(1):67-70. http://dx.doi.org/10.1016/j.neulet.2012.02.058. Epub 2012 Feb 25. PubMed PMID: 22390898.
Zolkowska D, Banks CN, Dhir A, Inceoglu B, Sanborn JR, McCoy MR, Bruun DA, Hammock BD, Lein PJ, Rogawski MA. Characterization of seizures induced by acute and repeated exposure to tetramethylenedisulfotetramine. J Pharmacol Exp Ther. 2012 May;341(2):435-46. http://dx.doi.org/10.1124/jpet.111.190579. Epub 2012 Feb 10. PubMed PMID: 22328574; PubMed Central PMCID: PMC3336809.
Dhir A, Rogawski MA. Role of neurosteroids in the anticonvulsant activity of midazolam. Br J Pharmacol. 2012 Apr;165(8):2684-91. http://dx.doi.org/10.1111/j.1476-5381.2011.01733.x. PubMed PMID: 22014182; PubMed Central PMCID: PMC3423249.
Porter RJ, Dhir A, Macdonald RL, Rogawski MA. Mechanisms of action of antiseizure drugs. Handb Clin Neurol. 2012;108:663-81. http://dx.doi.org/10.1016/B978-0-444-52899-5.00021-6. Review. PubMed PMID: 22939059.
Lossin C, Nam TS, Shahangian S, Rogawski MA, Choi SY, Kim MK, Sunwoo IN. Altered fast and slow inactivation of the N440K Nav1.4 mutant in a periodic paralysis syndrome. Neurology. 2012 Sep 4;79(10):1033-40. http://dx.doi.org/10.1212/WNL.0b013e3182684683. Epub 2012 Aug 22. PubMed PMID: 22914841.
Cao Z, Hammock BD, McCoy M, Rogawski MA, Lein PJ, Pessah IN. Tetramethylenedisulfotetramine alters Ca²+ dynamics in cultured hippocampal neurons: mitigation by NMDA receptor blockade and GABA(A) receptor-positive modulation. Toxicol Sci. 2012 Dec;130(2):362-72. http://dx.doi.org/10.1093/toxsci/kfs244. Epub 2012 Aug 13. PubMed PMID: 22889812; PubMed Central PMCID: PMC3529644.
French JA, Krauss GL, Biton V, Squillacote D, Yang H, Laurenza A, Kumar D, Rogawski MA. Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304. Neurology. 2012 Aug 7;79(6):589-96. http://dx.doi.org/10.1212/WNL.0b013e3182635735. Epub 2012 Jul 25. PubMed PMID: 22843280; PubMed Central PMCID: PMC3413761.
Rogawski MA. Migraine and Epilepsy—Shared Mechanisms within the Family of Episodic Disorders. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, editors. Jasper's Basic Mechanisms of the Epilepsies [Internet]. 4th edition. Bethesda (MD): National Center for Biotechnology Information (US); 2012. Available from http://www.ncbi.nlm.nih.gov/books/NBK98193/ PubMed PMID: 22787613.
Reddy DS, Rogawski MA. Neurosteroids — Endogenous Regulators of Seizure Susceptibility and Role in the Treatment of Epilepsy. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, editors. Jasper's Basic Mechanisms of the Epilepsies [Internet]. 4th edition. Bethesda (MD): National Center for Biotechnology Information (US); 2012. Available from http://www.ncbi.nlm.nih.gov/books/NBK98218/ PubMed PMID: 22787590.
Lossin C, Shi X, Rogawski MA, Hirose S. Compromised function in the Na(v)1.2 Dravet syndrome mutation R1312T. Neurobiol Dis. 2012 Sep;47(3):378-84. http://dx.doi.org/10.1016/j.nbd.2012.05.017. Epub 2012 Jun 4. PubMed PMID: 22677033.
Cao Z, Hulsizer S, Tassone F, Tang HT, Hagerman RJ, Rogawski MA, Hagerman PJ, Pessah IN. Clustered burst firing in FMR1 premutation hippocampal neurons: amelioration with allopregnanolone. Hum Mol Genet. 2012 Jul 1;21(13):2923-35. http://dx.doi.org/10.1093/hmg/dds118. Epub 2012 Mar 30. PubMed PMID: 22466801; PubMed Central PMCID: PMC3373240.
Dhir A, Lossin C, Rogawski MA. Propofol hemisuccinate suppresses cortical spreading depression. Neurosci Lett. 2012 Apr 11;514(1):67-70. http://dx.doi.org/10.1016/j.neulet.2012.02.058. Epub 2012 Feb 25. PubMed PMID: 22390898.
Zolkowska D, Banks CN, Dhir A, Inceoglu B, Sanborn JR, McCoy MR, Bruun DA, Hammock BD, Lein PJ, Rogawski MA. Characterization of seizures induced by acute and repeated exposure to tetramethylenedisulfotetramine. J Pharmacol Exp Ther. 2012 May;341(2):435-46. http://dx.doi.org/10.1124/jpet.111.190579. Epub 2012 Feb 10. PubMed PMID: 22328574; PubMed Central PMCID: PMC3336809.
Dhir A, Rogawski MA. Role of neurosteroids in the anticonvulsant activity of midazolam. Br J Pharmacol. 2012 Apr;165(8):2684-91. http://dx.doi.org/10.1111/j.1476-5381.2011.01733.x. PubMed PMID: 22014182; PubMed Central PMCID: PMC3423249.
2011
Rogawski MA, Federoff HJ. Disclosure of clinical trial results when product development is abandoned. Sci Transl Med. 2011 Sep 28;3(102):102cm29. http://dx.doi.org/10.1126/scitranslmed.3002939. Review. PubMed PMID: 21957167.
Stafstrom CE, Arnason BG, Baram TZ, Catania A, Cortez MA, Glauser TA, Pranzatelli MR, Riikonen R, Rogawski MA, Shinnar S, Swann JW. Treatment of infantile spasms: emerging insights from clinical and basic science perspectives. J Child Neurol. 2011 Nov;26(11):1411-21. http://dx.doi.org/10.1177/0883073811413129. Epub 2011 Jun 30. Review. PubMed PMID: 21719797.
Rogawski MA. Revisiting AMPA receptors as an antiepileptic drug target. Epilepsy Curr. 2011 Mar;11(2):56-63. http://dx.doi.org/10.5698/1535-7511-11.2.56. PubMed PMID: 21686307; PubMed Central PMCID: PMC3117497.
Kaminski RM, Rogawski MA. 11β-Hydroxylase inhibitors protect against seizures in mice by increasing endogenous neurosteroid synthesis. Neuropharmacology. 2011 Jul-Aug;61(1-2):133-7. http://dx.doi.org/10.1016/j.neuropharm.2011.03.019. Epub 2011 Mar 31. PubMed PMID: 21458468; PubMed Central PMCID: PMC3105122.
Stafstrom CE, Arnason BG, Baram TZ, Catania A, Cortez MA, Glauser TA, Pranzatelli MR, Riikonen R, Rogawski MA, Shinnar S, Swann JW. Treatment of infantile spasms: emerging insights from clinical and basic science perspectives. J Child Neurol. 2011 Nov;26(11):1411-21. http://dx.doi.org/10.1177/0883073811413129. Epub 2011 Jun 30. Review. PubMed PMID: 21719797.
Rogawski MA. Revisiting AMPA receptors as an antiepileptic drug target. Epilepsy Curr. 2011 Mar;11(2):56-63. http://dx.doi.org/10.5698/1535-7511-11.2.56. PubMed PMID: 21686307; PubMed Central PMCID: PMC3117497.
Kaminski RM, Rogawski MA. 11β-Hydroxylase inhibitors protect against seizures in mice by increasing endogenous neurosteroid synthesis. Neuropharmacology. 2011 Jul-Aug;61(1-2):133-7. http://dx.doi.org/10.1016/j.neuropharm.2011.03.019. Epub 2011 Mar 31. PubMed PMID: 21458468; PubMed Central PMCID: PMC3105122.
2010
Noebels JL, Avoli M, Rogawski M, Olsen R, Delgado-Escueta AV. "Jasper's Basic Mechanisms of the Epilepsies" Workshop. Epilepsia. 2010 Dec;51 Suppl 5:1-5. doi: 10.1111/j.1528-1167.2010.02792.x. PubMed PMID: 21208201.
Rogawski MA. Neurosteroids on the epilepsy chessboard-keeping seizures in check. Epilepsy Curr. 2010 Nov;10(6):161-3. doi: 10.1111/j.1535-7511.2010.01388.x. PubMed PMID: 21157546; PubMed Central PMCID: PMC3001027.
Dhir A, Zolkowska D, Murphy RB, Rogawski MA. Seizure protection by intrapulmonary delivery of propofol hemisuccinate. J Pharmacol Exp Ther. 2011 Jan;336(1):215-22. doi: 10.1124/jpet.110.173591. Epub 2010 Sep 13. PubMed PMID: 20837991.
Gasior M, Yankura J, Hartman AL, French A, Rogawski MA. Anticonvulsant and proconvulsant actions of 2-deoxy-D-glucose. Epilepsia. 2010 Aug;51(8):1385-94. doi: 10.1111/j.1528-1167.2010.02593.x. Epub 2010 May 17. PubMed PMID: 20491877.
Reddy DS, Rogawski MA. Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model. Epilepsy Res. 2010 May;89(2-3):254-60. doi: 10.1016/j.eplepsyres.2010.01.009. Epub 2010 Feb 20. PubMed PMID: 20172694; PubMed Central PMCID: PMC2854307.
Rogawski MA. Neurosteroids on the epilepsy chessboard-keeping seizures in check. Epilepsy Curr. 2010 Nov;10(6):161-3. doi: 10.1111/j.1535-7511.2010.01388.x. PubMed PMID: 21157546; PubMed Central PMCID: PMC3001027.
Dhir A, Zolkowska D, Murphy RB, Rogawski MA. Seizure protection by intrapulmonary delivery of propofol hemisuccinate. J Pharmacol Exp Ther. 2011 Jan;336(1):215-22. doi: 10.1124/jpet.110.173591. Epub 2010 Sep 13. PubMed PMID: 20837991.
Gasior M, Yankura J, Hartman AL, French A, Rogawski MA. Anticonvulsant and proconvulsant actions of 2-deoxy-D-glucose. Epilepsia. 2010 Aug;51(8):1385-94. doi: 10.1111/j.1528-1167.2010.02593.x. Epub 2010 May 17. PubMed PMID: 20491877.
Reddy DS, Rogawski MA. Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model. Epilepsy Res. 2010 May;89(2-3):254-60. doi: 10.1016/j.eplepsyres.2010.01.009. Epub 2010 Feb 20. PubMed PMID: 20172694; PubMed Central PMCID: PMC2854307.
2007
Macdonald RL, Rogawski MA. Cellular effects of antiepileptic drugs. In, Epilepsy: A Comprehensive Textbook, Second Edition (Engel, Jr J, Pedley TA, eds.), Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, pp. 1433–1445, 2007 (full text here).